FGen GmbH (“FGen”), a leader in comprehensive strain development of yeast, bacteria and fungi, today announced their plans of offering their services to US customers starting in January of 2020. They are planning and executing this expansion with the help of CYTO Consulting, a Boston-based consulting firm focused on helping international life-sciences clients open business operations in the US.
FGen recently received a prestigious INNOWWIDE Horizon 2020 grant and is planning on using the proceeds to drive the US commercialization strategy.
Read more about the FGen's expansion in this Press Release
